Greater adherence to the Mediterranean diet reduces the risk of heart attack, stroke and cardiovascular mortality by approximately 25-30%. This effect has been consistently demonstrated in randomised trials and large observational cohorts, and is supported by biological mechanisms including improvements in blood lipids, blood pressure, visceral fat and inflammatory markers.
The Mediterranean diet, which is rich in vegetables, fruit, legumes, whole grains, olive oil, nuts and fish, is one of the most extensively studied dietary patterns in the world. Large studies consistently show that people who closely follow this diet have a 25 to 30 percent lower risk of serious cardiovascular events such as a heart attack, an ischaemic stroke or death from a cardiac cause. This effect has been found across 32 independent observational cohorts and in randomised trials, making the evidence particularly robust (PMID 30817261, 34423871, 37571293, 23432189).
The best-known randomised trial is the PREDIMED study, conducted in 7447 Spanish adults at high cardiovascular risk. Participants who received extra olive oil or nuts alongside the Mediterranean diet had, after an average of nearly five years, an approximately 28 to 30 percent lower risk of serious cardiac events compared with the control group, which received low-fat dietary advice. An earlier methodological issue in the publication (not all participants had been individually randomised) was corrected and the paper was republished; sensitivity analyses confirmed that the outcomes held up (PMID 23432189, 30817261). No diet-related adverse effects were reported.
How exactly does this work? The diet improves multiple risk factors simultaneously. Randomised research shows that it significantly reduces waist circumference, visceral fat (the dangerous fat surrounding the organs) and triglycerides (a type of blood fat). Blood pressure, cholesterol levels and inflammatory markers in the blood also improve measurably (PMID 25447615, 39125324, 34423871). Scientists additionally discovered a 'metabolic signature' of 67 substances in the blood that reflects the action of this diet in the body. Using a technique that partly rules out confounding factors (Mendelian randomisation), it was confirmed that this pattern likely also causally contributes to less coronary artery disease and fewer strokes (PMID 32406924).
The diet also appears to be beneficial for blood sugar regulation and may lower the risk of type 2 diabetes. Mechanisms cited include its anti-inflammatory and antioxidant components, along with favourable effects on the gut microbiome (PMID 32726990, 34423871). There is further evidence that the Mediterranean diet protects against cognitive decline and Alzheimer's disease, but this evidence is weaker and is largely based on observational research (PMID 34423871).
One nuance deserves attention: it remains uncertain whether the protective effect stems primarily from the overall dietary pattern as a whole, or from specific components such as olive oil, nuts or fish individually. Further research is needed to disentangle this (PMID 25447615). The link with a longer lifespan is also associational and has not yet been conclusively proven to be causal (PMID 34423871, 37571293). Nevertheless, the overall picture for cardiovascular protection is more solidly supported than for almost any other dietary pattern.
4 PMIDs were used for the primary cardiovascular effect (including the PREDIMED RCT and meta-analyses/large cohort reviews), supplemented by 5 additional PMIDs covering mechanisms, metabolomics and risk factors. Total participant numbers have not been summed per study, but PREDIMED alone encompasses 7447 participants; the 32 cohorts in the meta-analyses include tens of thousands of additional participants.